Related Experiment Video
Updated: Oct 4, 2025

Characterization of pH-Dependent Reversible Self-Assembly of Amyloid Beta 1-40-Coated Gold Colloids
Published on: March 21, 2025
Molecular insights into the primary nucleation of polymorphic amyloid β dimers in DOPC lipid bilayer membrane
Olga Press-Sandler1,2, Yifat Miller1,2
1Department of Chemistry, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
Abstract:
Alzheimer's disease (AD) pathology is characterized by loss of memory cognitive and behavioral deterioration. One of the hallmarks of AD is amyloid β (Aβ) plaques in the brain that consists of Aβ oligomers and fibrils. It is accepted that oligomers, particularly dimers, are toxic species that are produced extracellularly and intracellularly in membranes. It is believed that the disruption of membranes by polymorphic Aβ oligomers is the key for the pathology of AD. This is a first study that investigate the effect of polymorphic "α-helix/random coil" and "fibril-like" Aβ dimers on 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) membrane. It has been found that the DOPC membrane promotes Aβ1-42 "fibril-like" dimers and impedes Aβ1-42 "α-helix/random coil" dimers. The N-termini domains within Aβ1-42 dimers play a role in Aβ aggregation in membrane milieus. In addition, the aromatic π-π interactions (involving residues F19 and F20 in Aβ1-42 ) are the driving forces for the hydrophobic interactions that initiate the primary nucleation of polymorphic Aβ1-42 dimers within DOPC membrane. Finally, the DOPC bilayer membrane thickness is locally decreased, and it is disrupted by an embedded distinct Aβ1-42 dimer, due to relatively large contacts between Aβ1-42 monomers and the DOPC membrane. This study reveals insights into the molecular mechanisms by which polymorphic early-stage Aβ1-42 dimers have distinct impacts on DOPC membrane.
Insights
Alzheimer's disease (AD) pathology involves amyloid-beta (Aβ) dimers disrupting brain membranes. This study reveals how different Aβ dimer structures impact lipid bilayers, offering insights into AD's molecular origins.
Area of Science:
- Biochemistry
- Neuroscience
- Molecular Biology
Background:
- Alzheimer's disease (AD) is marked by cognitive decline and brain amyloid-beta (Aβ) plaques.
- Aβ oligomers, especially dimers, are considered toxic species that disrupt cell membranes.
- Understanding Aβ dimer interactions with membranes is crucial for AD pathogenesis.
Purpose of the Study:
- To investigate the impact of polymorphic Aβ dimers on 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) membranes.
- To elucidate the role of Aβ dimer structure and N-termini domains in membrane interactions.
- To identify the driving forces behind Aβ dimer aggregation within lipid bilayers.
Main Methods:
- Computational modeling and simulations were used to study Aβ dimer interactions.
- Analysis of the effects of Aβ dimer conformation ('α-helix/random coil' vs. 'fibril-like') on DOPC membranes.
- Investigation of the role of specific amino acid residues (F19, F20) and N-termini domains in Aβ aggregation.
Main Results:
- DOPC membranes promote 'fibril-like' Aβ dimers while impeding 'α-helix/random coil' Aβ dimers.
- Aβ dimer N-termini domains influence aggregation within membrane environments.
- Aromatic π-π interactions involving F19 and F20 drive hydrophobic interactions and nucleation of Aβ dimers.
- Aβ dimers decrease DOPC membrane thickness and cause disruption due to extensive monomer-membrane contacts.
Conclusions:
- Polymorphic Aβ dimers exhibit distinct effects on DOPC membranes.
- Membrane-induced conformational changes and specific residue interactions are key in Aβ aggregation.
- This research provides molecular insights into early-stage Aβ dimer interactions with lipid bilayers, relevant to Alzheimer's disease.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Mechanisms of Membrane Domain Formation
Another mechanism for membrane domain formation involves membrane proteins interacting with...

